Label: LIDOCAINE PAIN RELIEF patch

  • NDC Code(s): 0121-0970-01, 0121-0970-05, 0121-0970-30
  • Packager: PAI Holdings, LLC dba PAI Pharma
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated May 24, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient(s)

    Lidocaine 4%

  • Purpose

    Topical anesthetic

  • Uses

    Temporary relief of pain

  • Warnings

    For external use only

    Do not use

    • more than one patch at a time
    • on wounds or damaged, broken or irritated skin
    • if you are allergic to any ingredients of this product

    When using this product

    • use only as directed          • read and follow all directions and warnings
    • do not allow contact with eyes and mucous membranes
    • do not bandage tightly      • do not apply local heat such as a heating pad
    • do not use other topical anesthetics at the same time

    Stop use and ask a doctor if

    • localized skin reactions occur, such as rash, itching, redness, irritation,
      pain, swelling and blistering
    • conditions worsen
    • symptoms persist for more than 7 days
    • symptoms clear up and occur again within a few days

    if pregnant or breast-feeding, 

    ask a healthcare professional before use.

    Keep out of reach of children

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    Adults and children over 12 years:

    • clean and dry affected area
    • remove film from patch and apply to the skin
    • apply one patch to affected area not more than 3 to 4 times a day
    • remove patch from the skin after at most 12-hour application

    Children under 12 years of age: consult a doctor

  • Inactive ingredients

    dihydroxyaluminum aminoacetate, disodium edetate, gelatin, glycerin, kaolin, methylparaben, polyacrylic acid, polyvinyl
    alcohol, propylene glycol, propylparaben, sodium carboxymethylcellulose, sodium polyacrylate, D-sorbitol, tartaric acid, urea, water

  • Comments or Questions:

    1-800-845-8210

    ††This product is not manufactured or distributed by Chattem, Inc., distributor of Aspercreme® Lidocaine Patch.

  • Distributed by

    PAI LOGO

     MADE IN JAPAN

    C09750050222 R02/22

  • Principal Display Panel

    lidocaine-patch

    lidocaine patch

  • Principal Display Panel - 30 patches

    NDC 0121-0970-30

    Lidocaine Pain Relief Patch

    4% Lidocaine / Topical Anesthetic

    Lidocaine Pain Relief 30 Patches
  • INGREDIENTS AND APPEARANCE
    LIDOCAINE PAIN RELIEF 
    lidocaine pain relief patch
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0121-0970
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE560 mg
    Inactive Ingredients
    Ingredient NameStrength
    DIHYDROXYALUMINUM AMINOACETATE (UNII: DO250MG0W6)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    GELATIN (UNII: 2G86QN327L)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    KAOLIN (UNII: 24H4NWX5CO)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    POLYACRYLIC ACID (250000 MW) (UNII: 9G2MAD7J6W)  
    POLYVINYL ALCOHOL (100000 MW) (UNII: 949E52Z6MY)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED (UNII: K679OBS311)  
    SODIUM POLYACRYLATE (2500000 MW) (UNII: 05I15JNI2J)  
    SORBITOL (UNII: 506T60A25R)  
    TARTARIC ACID (UNII: W4888I119H)  
    UREA (UNII: 8W8T17847W)  
    WATER (UNII: 059QF0KO0R)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:0121-0970-0512 in 1 CASE04/03/2023
    15 in 1 CARTON
    1NDC:0121-0970-011 in 1 POUCH; Type 0: Not a Combination Product
    2NDC:0121-0970-306 in 1 CASE07/29/2024
    230 in 1 CARTON
    2NDC:0121-0970-011 in 1 POUCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph Drug505G(a)(3)04/03/2023
    Labeler - PAI Holdings, LLC dba PAI Pharma (044940096)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!